Angiosarcoma of the scalp diagnosed by the presence of neck inflammation: a case report

Abstract

Angiosarcoma is an uncommon malignancy, which spread out from the endothelial cells of vessels. Scalp angiosarcoma with cervical lymph node metastasis is particularly rare. This article describes a rare case of angiosarcoma of the scalp, presenting as neck inflammation. Imaging procedures such as computed tomography (CT), magnetic resonance image (MRI) and ultrasonography (US) were not sufficient to diagnose this case. A needle biopsy provided an effective and accurate diagnosis of cervical lymph node metastasis. Additional observation and physical examination was required to diagnose the origin of the primary cancerous lesion. Once the angiosarcoma diagnosis was confirmed histologically, sequential weekly and monthly docetaxel (DTX) treatment was effective in preventing reoccurrence. Nonetheless, the optimization of angiosarcoma treatment remains a future goal. Although patients generally describe pain and swelling at the primary lesion site, this patient complained only of painful neck inflammation, without any indication of pain or swelling of the scalp. A revised diagnostic protocol should note that cervical lymph node metastasis of unknown primary origin may result from angiosarcoma of the scalp.

Keywords

angiosarcoma / docetaxel / neck inflammation / needle biopsy / scalp

References

[1] Arribas-Garcia I, Dominguez MF, Alcala-Galiano A. Oral primary angiosarcoma of the lower lip mucosa: report of a case in a 15-year-old boy. Head Neck, 2008, 30(10): 1384-1388.

[2] Guadagnolo BA, Zagars GK, Araujo D. Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp. Head Neck, 2011, 33(5): 661-667.

[3] Nakamura Y, Hori E, Furuta J. Complete long-term response of angiosarcoma of the scalp with cervical lymph node metastases treated with a combination of weekly and monthly docetaxel. Br J Dermatol, 2010, 163(6): 1357-13578.

[4] Terada T. Fatal poorly differentiated angiosarcoma of the scalp. Int J Clin Exp Pathol, 2010, 3(5): 541-544.

[5] Pawlik TM, Paulino AF, McGinn CJ. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer, 2003, 98(8): 1716-1726.

[6] Uchiyama Y, Murakami S, Kishino M. A case report of primary gingival angiosarcoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009, 108(6): e17-e21.

[7] Terada T. Angiosarcoma of the oral cavity. Head Neck Pathol, 2011, 5(1): 67-70.

[8] Cerezo L, Raboso E, Ballesteros AI. Unknown primary cancer of the head and neck: a multidisciplinary approach. Clin Transl Oncol, 2011, 13(2): 88-97.

[9] Nassenstein K, Veit-Haibach P, Stergar H. Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography. Acta Radiol, 2007, 48(10): 1101-1108.

[10] Paul SA, Stoeckli SJ, von Schulthess GK. FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary. Eur Arch Otorhinolaryngol, 2007, 264(2): 189-195.

[11] Pohar-Marinsek Z, Lamovec J. Angiosarcoma in FNA smears: diagnostic accuracy, morphology, immunocytochemistry and differential diagnoses. Cytopathology, 2010, 21(5): 311-319.

[12] Itakura E, Yamamoto H, Oda Y. Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas. J Surg Oncol, 2008, 97(1): 74-81.

[13] Nagano T, Yamada Y, Ikeda T. Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer, 2007, 110(3): 648-651.

[14] Penel N, Lansiaux A, Adenis A. Angiosarcomas and taxanes. Curr Treat Options Oncol, 2007, 8(6): 428-434.

[15] Abraham JA, Hornicek FJ, Kaufman AM. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol, 2007, 14(6): 1953-1967.